Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75afa2886cc8bf1a0baf3f6d37bb3c7d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2299-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27 |
filingDate |
2003-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40e5d64bd59be7827608045b039fbf33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_397e86c21d5d10e4c280eca41bf8a0ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b933daf69b14d7b8d9c386af472fc42 |
publicationDate |
2005-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20050090430-A |
titleOfInvention |
Human growth hormone crystals and methods for preparing them |
abstract |
The present invention relates to human growth hormone crystals or human growth hormone derivative crystals having stable and prolonged release properties and to compositions or formulations containing such crystals. The present invention also provides a method for producing these crystals and a method for producing the composition. In addition, the present invention provides a method for treating an individual with a disorder associated with human growth hormone deficiency and a disorder that is ameliorated by treatment with human growth hormone using these crystals and compositions or agents. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101524880-B1 |
priorityDate |
2002-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |